$ 263.73+2.29 (+0.88%)
OpenPrice at market open
—LowLowest price today
—52-Week HighHighest past 52 weeks
—HighHighest price today
—52-Week LowLowest past 52 weeks
—Market Cap.Total company value
630.04BToday’s VolumeShares traded today
5.46MAvg. VolumeAverage shares traded
7.48MP/E RatioPrice to earnings ratio
30.22Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
IPO Date
1962-01-02Headquarters
New Brunswick, USCEO
Joaquin DuatoSector
HealthcareIndustry
Drug Manufacturers - GeneralFinancial Statements
Earnings
News

Johnson & Johnson (NYSE:JNJ) & Zentalis Pharmaceuticals (NASDAQ:ZNTL) Head-To-Head Contrast
2 days agoJNJdefenseworld.net

J&J Stock Ahead of Q3 Earnings: Should You Buy, Sell or Hold?
4 days agoJNJzacks.com

4 Dividend Stocks Boomers Can Safely Buy Now and Hold Forever
4 days agoJNJ247wallst.com

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis
4 days agoJNJgurufocus.com

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis
4 days agoJNJprnewswire.com

HALO Wins Court Order Blocking Merck's Keytruda SC in Europe
4 days agoJNJzacks.com
News
Related Companies
ABBVAbbVie Inc.
281.04
AMGNAmgen Inc.
417.57
AZNAstraZeneca PLC
158.33
BMYBristol-Myers Squibb Company
57.58














